Diabetes
Risk and burden of incident diabetes in long COVID
Risk and burden of incident diabetes in long COVID

Diabetes identification and management should be included in post-acute care strategies

January 2023

Sleep Patterns Influence Glycemic Control in Diabe
Sleep Patterns Influence Glycemic Control in Diabetes: Mendelian Randomization Study

A Mendelian randomization study elucidates the causal relationship between sleep traits and glycemic control, highlighting the potential impact of sleep interventions on diabetes management and outcomes.

January 2023

Hypoglycemia Linked to QT Prolongation in Type 2 D
Hypoglycemia Linked to QT Prolongation in Type 2 Diabetes

Severe hypoglycemia is associated with an increased risk of QTc prolongation in individuals with type 2 diabetes, emphasizing the importance of glycemic management and monitoring to prevent adverse cardiac events in this population.

December 2022

Exercise Counteracts Diabetes Damage Through Antio
Exercise Counteracts Diabetes Damage Through Antioxidant Mechanisms

Exercise induces the release of natural antioxidants and promotes angiogenesis, mitigating the damaging effects of diabetes on vascular health and providing insights into the therapeutic benefits of physical activity in diabetes management.

December 2022

Long-Term Diabetes Prevention Trial Shows Metformi
Long-Term Diabetes Prevention Trial Shows Metformin and Lifestyle Interventions Ineffective in Reducing Major Cardiovascular Events

Neither metformin nor lifestyle interventions reduce major cardiovascular events in the long term, despite their efficacy in preventing diabetes, highlighting the need for alternative strategies to mitigate cardiovascular risk in high-risk populations.

December 2022

Predictive Markers for Fatty Liver Disease and Ass
Predictive Markers for Fatty Liver Disease and Associated Metabolic Conditions

Fatty liver disease is associated with various metabolic disorders, including type 2 diabetes and cardiovascular diseases, underscoring the importance of identifying predictive markers to facilitate early intervention and risk stratification.

December 2022

Insomnia Linked to Increased Risk of Type 2 Diabet
Insomnia Linked to Increased Risk of Type 2 Diabetes

Insomnia is associated with an elevated risk of developing type 2 diabetes, suggesting the potential role of sleep disturbances in the pathogenesis of metabolic disorders and the importance of sleep interventions in diabetes prevention and management.

December 2022

Impact of Sleep Light Exposure on Cardiometabolic
Impact of Sleep Light Exposure on Cardiometabolic Function: Insights from Nocturnal Studies

Nocturnal exposure to light during sleep disrupts cardiometabolic function, leading to greater insulin resistance, elevated heart rate, and reduced heart rate variability upon waking, highlighting the importance of optimizing sleep environments to promote metabolic health.

November 2022

Exercise in Long COVID: Implications for Diabetes
Exercise in Long COVID: Implications for Diabetes and Depression Management

Exercise induces the release of circulating factors that mediate the anti-inflammatory response, suggesting potential therapeutic benefits for managing diabetes and depression in individuals with long COVID.

November 2022

Insomnia Symptoms Linked to Higher HbA1c Levels in
Insomnia Symptoms Linked to Higher HbA1c Levels in Individuals With Type 2 Diabetes

Frequent insomnia symptoms are associated with higher levels of glycated hemoglobin (HbA1c) in individuals with type 2 diabetes, suggesting a potential bidirectional relationship between sleep disturbances and glycemic control.

November 2022